RDEA119 and Sorafenib Combination Dose Escalation Study

Clinical trial NCT00785226 · COMPLETED

Trial details

NCT number: NCT00785226
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Cancer

Start date: 2008-11-01
Primary completion: 2012-04-01
Enrollment: 62

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.